Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Crescendo Biologics Ltd.

https://www.crescendobiologics.com/

Latest From Crescendo Biologics Ltd.

Crescendo, BerGenBio Find Support For Cancer Studies

European biotech companies are finding diverse ways of finding support and financing to propel their potential first-in-class therapies into clinical studies, including sponsorship by patient charities as well as private placements.

ImmunoOncology Financing

Eyes On Divestments, Revised Guidance Ahead Of Takeda's Q1

As Takeda prepares to report its first full quarter post-Shire next week, eyes will be on further strategic divestments and trends that could lead to a raising of guidance in Q2.

Japan Business Strategies

New Takeda R&D Collabs Aim To Boost IO Pipeline

In moves aimed at boosting its presence in the immuno-oncology field, Takeda unveils a series of new research collaborations it believes will lead to pipeline gains in this critical field over the next few years.

Cancer Research and Development Strategies

Deal Watch: Gilead Signs Two Deals In Two Days To Increase R&D Emphasis

As it moves away from virology, Gilead’s signs fibrosis collaboration with Scholar Rock. Novartis seeks to acquire CMDO that manufactures Kymriah, while Intrexon regains control of CAR-T program partnered with Merck KGAA. More deals from over the holiday period… 

See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Transgenics
    • Large Molecule
      • Antibodies
UsernamePublicRestriction

Register